When living with lupus, connecting with others can be challenging, says columnist Candace Semien. Letter writing and pen pals can help.

There is a space that too many people with lupus are forced to live in, between being considered “disabled” and being expected to function as though nothing were wrong. I know that space. Many of you ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Even though I know the characters with lupus are fictional, I’m filled with empathy and a little ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Seattle Children’s has been cleared by the U.S. Food and Drug ...

Telitacicept, a B-cell-targeting therapy developed by RemeGen, outperformed a placebo at reducing the severity of systemic lupus erythematosus (SLE) in a Phase 3 clinical trial in China, the company ...

Ventus Therapeutics plans to develop a new treatment candidate for lupus and other inflammatory diseases marked by the activation of the type 1 interferon immune system pathway, the company recently ...

After a proof-of-concept clinical trial failed to meet its main goal, Immunovant announced that it will not pursue further development of its experimental therapy IMVT-1402 (imeroprubart) as a ...

Marisa Zeppieri is a journalist, author of two books, and former Mrs. New York 2015. Her verticals include health, nutrition, food, recipe creation, and food photography. She is also the founder of ...

Depression and anxiety are more likely in people with systemic lupus erythematosus (SLE) who also are at a greater risk of heart disease, like those with obesity or high blood pressure, a study ...

A Phase 2b clinical trial of ESK-001, an oral treatment for systemic lupus erythematosus (SLE), has begun dosing patients, according to its developer Alumis. The trial, called LUMUS, is expected to ...

Let’s start with a little story, shall we? It’s currently 142 F outside. OK, that might be a slight exaggeration, but not by much. I’m living through one of the most brutal heat waves my area has seen ...

The U.S. Food and Drug Administration (FDA) has approved Gazyva (obinutuzumab) as an add-on treatment for adults with lupus nephritis, a form of lupus marked by kidney damage. Lupus is an autoimmune ...